Q4 2024 Sotera Health Co Earnings Call Transcript
Key Points
- Sotera Health Co (SHC) reported its 19th consecutive year of annual revenue growth, highlighting the resilience of its business model.
- The company achieved $1.1 billion in revenue for 2024 with approximately 50% adjusted EBITDA margins.
- Customer satisfaction rates remained high, exceeding 80%, reflecting strong customer service.
- Sotera Health Co (SHC) successfully refinanced its capital structure, extending maturities to 2031, and maintained strong liquidity.
- The company made significant progress in its strategic priorities, including capacity expansion in its Sterigenics business and enhancements in its US EO facilities.
- Fourth quarter revenue declined by 6.5% and adjusted EBITDA decreased by 8.3% compared to the same period in 2023.
- Nordion's fourth quarter revenue decreased by 29% due to unfavorable volume mix and foreign currency exchange rates.
- Nelson Labs experienced a 7.3% decline in revenue for the fourth quarter, driven by unfavorable volume mix.
- Adjusted EPS for the fourth quarter was $0.21, a decrease from the previous year.
- The company faces potential headwinds from foreign exchange rates and tariffs, which could impact future financial performance.
Good morning, and welcome to the Sotera Health Fourth Quarter and Full Year 2024 Conference Call. All participants will be in listen-only mode. (Operator Instructions) Please note, this event is being recorded. I would now like to turn the conference over to Vice President of Investor Relations and Treasurer, Mr. Jason Peterson. Jason, please go ahead.
Good morning, and thank you. Welcome to Sotera Healthâs fourth quarter and full year 2024 earnings call. You can find todayâs press release and accompanying supplemental slides on the Investors section of our website at soterahealth.com. This webcast is being recorded, and a replay will be available in the Investors section of the Sotera Health website.
On the call with me today are Chairman and Chief Executive Officer, Michael Petras; and Chief Financial Officer, Jon Lyons. During the call, some of our comments may be considered forward-looking statements. The matters addressed in these statements are subject to risks
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
